A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers

Introduction: Over 50% of patients with colorectal cancer (CRC) will progress and/or develop metastases. Biomarkers capable of predicting progression, risk stratification and therapeutic benefit are needed. Cancer stem cells are thought to be responsible for tumor initiation, dissemination and treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Langan, Russell C., Mullinax, John E., Ray, Satyajit, Raiji, Manish T., Schaub, Nicholas, Xin, Hong-Wu, Koizumi, Tomotake, Steinberg, Seth M., Anderson, Andrew, Wiegand, Gordon, Butcher, Donna, Anver, Miriam, Bilchik, Anton J., Stojadinovic, Alexander, Rudloff, Udo, Avital, Itzhak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366478/
https://www.ncbi.nlm.nih.gov/pubmed/22670157
http://dx.doi.org/10.7150/jca.4542

Ejemplares similares

Ejemplares similares